China Universal Asset Management »

Zenas Biopharma shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Zenas Biopharma (ZBIO) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $483k 13k 36.31

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Alphabet Inc-cl A Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc-class A Common Stock (META)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Alphabet Inc-cl C Common Stock (GOOG)
Vertex Pharmaceuticals Common Stock (VRTX)
Gilead Sciences Common Stock (GILD)
Proshares Ultra Gold Etp (UGL)
Netflix Common Stock (NFLX)
Spdr Gold Minishares Trust Etp (GLDM)

View all positions for China Universal Asset Management

Top funds holding Zenas Biopharma

Sr One Capital Management
FMR
Enavate Sciences GP
NEA Management Company
Federated Investors
Fairmount Funds Management
NVP Associates
BlackRock
Vanguard Group
Novo A/S
Polar Capital Holdings
Wellington Management Company
Vivo Capital
Arrowpoint Asset Management
EcoR1 Capital

View all funds holding Zenas Biopharma